Agilent: Biologics growth presents biggest consumables opportunity
The growth in biologics has given Agilent Technologies a “huge opportunity for services and consumables,” according to the firm’s CEO-Elect.
Archives for November 21, 2014
Research institute wins $11.9m NIH contract to make thermostable TB vaccine
With the goal of developing a thermostable tuberculosis vaccine, IDRI (Infectious Disease Research Institute) was awarded a contract from the NIH’s National Institute of Allergy and Infectious Diseases that could be worth up to $11.9m.
Amgen launches $200m biomanufacturing facility in Singapore
Amgen has completed construction of its first $200m next-gen biomanufacturing facility in Singapore, which is outfitted with single-use technology to allow for greater flexibility.
Novartis to keep complex biologics manufacturing in-house
Novartis says it will keep biomanufacturing in-house and outsource more production of its small molecule portfolio in a strategy mirroring its Big Pharma peers.